Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Xiuru Su"'
Publikováno v:
Schizophrenia, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract Patients with schizophrenia (SCZ) smoke up to three times more than general people. However, there are conflicting results regarding the relationship between tobacco smoke and clinical symptom severity in SCZ. The aim of this study was to as
Externí odkaz:
https://doaj.org/article/2259989989df4c62b117e59c2cb16e49
Publikováno v:
Schizophrenia, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract High frequency (HF)-rTMS has been shown to improve cognitive functions in patients with schizophrenia (SCZ). This study aimed to investigate whether COX-2 rs5275 variants were associated with cognitive improvements following rTMS treatment i
Externí odkaz:
https://doaj.org/article/a3baeaeeb6544e808e94809554448585
Publikováno v:
Schizophrenia, Vol 10, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/1845f153c7f8402ab1108de3fa993013
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Brain-derived neurotrophic factor (BDNF) is reported to be involved in cognitive decline in patients with schizophrenia (SZ). Previous studies have found that cognitive deficits remain stable during the chronic disease phase in SZ, but the f
Externí odkaz:
https://doaj.org/article/6a05cba8e94c4e2089138ecc119d8f9e
Autor:
Xiuru Su, Long Zhao, Yujie Shang, Yingnan Chen, Xiaowen Liu, Xuan Wang, Meihong Xiu, Huijing Yu, Lijun Liu
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Multiple lines of evidence demonstrate that high-frequency (HF) repetitive transcranial magnetic stimulation (rTMS) may improve clinical outcomes in patients with schizophrenia (SCZ). However, the efficacy of HF-rTMS on psychiatric symptoms remains u
Externí odkaz:
https://doaj.org/article/b854835df9e4467594083c705ca4372d
Publikováno v:
Antioxidants, Vol 11, Iss 4, p 646 (2022)
Schizophrenia (SCZ) is associated with aberrant redox regulation in the early stages of brain development. There is growing evidence that the antioxidant defense system is closely associated with the therapeutic response to antipsychotics in SCZ pati
Externí odkaz:
https://doaj.org/article/0a4a2b575bff417ab3eac5d53c88800c
Autor:
Meihong Xiu, Fengchun Wu, Xiuru Su, Haixia Liu, Xuan Wang, Xiuling Pan, Xuan Zhang, Xinyan Lu, Long Zhao, Yingnan Chen, Yujie Shang
Publikováno v:
Current neuropharmacology.
Abstract: Previous literatures have reported that high-frequency (HF) neuronavigated repetitive transcranial magnetic stimulation (rTMS) may improve neurocognitive functioning in patients with schizophrenia. Nonetheless, the heterogeneity of the rese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b5fda46914c23a712b3808b2a2ab9ff
https://pubmed.ncbi.nlm.nih.gov/35927806
https://pubmed.ncbi.nlm.nih.gov/35927806
Publikováno v:
Metabolomics : Official journal of the Metabolomic Society. 18(7)
Olanzapine (OLA) is one of the most commonly used second-generation antipsychotics for the treatment of schizophrenia. However, the heterogeneity of therapeutic response to OLA among schizophrenia patients deserves further exploration. The role of ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b698afd9b187c92d811a775b3449c126
https://pubmed.ncbi.nlm.nih.gov/35819637
https://pubmed.ncbi.nlm.nih.gov/35819637
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Brain-derived neurotrophic factor (BDNF) is reported to be involved in cognitive decline in patients with schizophrenia (SZ). Previous studies have found that cognitive deficits remain stable during the chronic disease phase in SZ, but the findings w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb82ab6ac0bfd80b840a88fcd84ac5f6
http://europepmc.org/articles/PMC8501135
http://europepmc.org/articles/PMC8501135
Autor:
Meihong Xiu, Fengchun Wu, Xiuru Su, Xuan Wang, Xiuling Pan, Xuan Zhang, Xinyan Lu, Long Zhao, Yingnan Chen, Yujie Shang, Lin Zhu, Shulan Lu, Xiaolin Zhu
Publikováno v:
Current neuropharmacology.
Objectives: There is emerging evidence that high-frequency (HF) repetitive transcranial magnetic stimulation (rTMS) may promote weight loss in individuals with obesity in the general population. However, no study has been conducted on patients with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4330d45b66888ee07b62612e907c601a
https://pubmed.ncbi.nlm.nih.gov/35611778
https://pubmed.ncbi.nlm.nih.gov/35611778